According to the Zhitong Finance APP, shandong jincheng pharmaceutical group (300233.SZ) announced that its wholly-owned subsidiary shanghai jincheng suzhi pharmaceutical co., ltd. (referred to as "jincheng suzhi") has received the cephalosporin benzylpenicillin dry suspension pharmaceutical registration certificate issued by the National Medical Products Administration and is deemed to have passed the evaluation of generic drug quality and efficacy consistency.